ID   HEY-1B
AC   CVCL_AZ64
SY   HEY1B; Hey1b
DR   BTO; BTO:0005706
DR   cancercelllines; CVCL_AZ64
DR   Wikidata; Q54883216
RX   PubMed=3731068;
RX   PubMed=10637068;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0297 ! HEY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 11
//
RX   PubMed=3731068;
RA   Baumal R., Law J., Buick R.N., Kahn H., Yeger H., Sheldon K.,
RA   Colgan T., Marks A.;
RT   "Monoclonal antibodies to an epithelial ovarian adenocarcinoma:
RT   distinctive reactivity with xenografts of the original tumor and a
RT   cultured cell line.";
RL   Cancer Res. 46:3994-4000(1986).
//
RX   PubMed=10637068; DOI=10.1006/gyno.1999.5668;
RA   Kushner D.M., Paranjape J.M., Bandyopadhyay B., Cramer H., Leaman D.W.,
RA   Kennedy A.W., Silverman R.H., Cowell J.K.;
RT   "2-5A antisense directed against telomerase RNA produces apoptosis in
RT   ovarian cancer cells.";
RL   Gynecol. Oncol. 76:183-192(2000).
//